PetDx published a study today showing that OncoK9, its multi-cancer early detection test for dogs using next-generation sequencing (NGS) technology, performs similarly in real-world veterinary practice settings as in the CANcer Detection in Dogs (CANDiD) study, the test’s landmark clinical validation study.
Click here for original story, Performance of OncoK9 in real-world veterinary practice mirrors clinical validation study
Source: Phys.org